多重耐药结核病的临床视角:一个概述
Arpit Raj1, Vikrant Abbot2, Kapil Kumar3
1School of Pharmaceutical Sciences, Apeejay Stya University, Gurugram, 122103, Haryana, India.
Microbial pathogenesis
|October 17, 2025
概括
纳米技术提供了一种有希望的方法来打击结核病 (TB),通过提高抗结核病药物的疗效,并使得早期检测Mycobacterium. 这一创新战略旨在克服耐药性并改善治疗结果.
科学领域:
- 制药科学 制药科学
- 纳米技术纳米技术
- 传染性疾病 传染性疾病
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,因药物耐药性的演变而复杂化,包括多药耐药 (MDR) 和广泛耐药 (XDR) 菌株.
- 目前的抗结核病药物开发面临着有效性和药物输送方面的挑战,导致治疗失败.
- 耐药细菌菌株的出现需要新的治疗策略来有效地治疗结核病.
研究的目的:
- 审查纳米技术的最新进展,以开发更有效的抗结核病药物.
- 探索纳米技术在早期检测和Mycobacteria的分化中的潜力.
- 突出政府支持结核病控制和治疗的倡议.
主要方法:
- 纳米颗粒 (NP) 封装抗结核病药物以改善药理动力学和减少剂量.
- 在诊断应用中利用纳米材料独特的物理化学和光学特性.
- 审查综合纳米技术与结核病诊断和治疗的跨学科研究.
主要成果:
- 基于纳米技术的药物输送系统显示出增强治疗疗效和降低药物剂量要求的潜力.
- 纳米材料为快速准确地检测和分化Mycobacteria提供了机会.
- 纳米技术在抗结核战略中的整合正在推进诊断和治疗程序.
结论:
- 纳米技术在抗结核病药物中带来了范式的转变,提供了更好的治疗效率和诊断能力.
- 在NP中封装抗结核病药物可以克服与耐药性相关的挑战,并改善患者的治疗结果.
- 持续的研究和政府举措对于利用纳米技术在抗击结核病方面的全部潜力至关重要.
更多相关视频
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
9.0K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
19.2K
相关概念视频
01:28Pulmonary Tuberculosis V
533
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
533
01:29Pulmonary Tuberculosis I
822
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
822
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
01:30Development of Antibiotic Resistance
1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
01:29Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
01:26Pulmonary Tuberculosis IV
473
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
473